Symbol="MYMD"
AssetType="Common Stock"
Name="MyMD Pharmaceuticals Inc"
Description="MyMD Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, is dedicated to the development of pharmaceutical products targeting aging and age-related diseases; Autoimmune diseases; and chronic pain, anxiety, and sleep disorders. The company is headquartered in Tampa, Florida."
CIK="1321834"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="201 GROVE RD, THOROFARE, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="47626200"
EBITDA="-28182912"
PERatio="None"
PEGRatio="None"
BookValue="0.252"
DividendPerShare="0"
DividendYield="0"
EPS="-0.33"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.426"
ReturnOnEquityTTM="-0.95"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.33"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="3.083"
EVToRevenue="-"
EVToEBITDA="-3.332"
Beta="4.037"
num_52WeekHigh="3.93"
num_52WeekLow="0.8"
num_50DayMovingAverage="1.296"
num_200DayMovingAverage="1.671"
SharesOutstanding="44930400"
DividendDate="2019-11-25"
ExDividendDate="None"
symbol="MYMD"
open="1.09"
high="1.09"
low="1.01"
price="1.02"
volume="497118.00"
latest_trading_day="2023-08-28"
previous_close="1.06"
change="-0.04"
change_percent="-3.7736%"
aroon_positive_momentum_days="33"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="641932"
Change_recent_avg="-0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-1.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_negative_thumbnail_id_2="125"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0051.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="643"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_positive_thumbnail_id_2="644"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0064.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
